Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Dichloroacetic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 26Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Saol's SL1009 NDA Accepted for Pyruvate Dehydrogenase Deficiency
    Saol's SL1009 NDA Accepted for Pyruvate Dehydrogenase Deficiency

    28 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/saol-therapeutics-announces-fda-acceptance-of-new-drug-application-for-sl1009-for-treatment-of-pyruvate-dehydrogenase-complex-deficiency-302361297.html

    PR NEWSWIRE
    28 Jan 2025
    Share Share
    Keeping Cancer Out of Breath Blocks Drug Resistance
    Keeping Cancer Out of Breath Blocks Drug Resistance

    27 Aug 2018

    // R&DMAG

    https://www.rdmag.com/news/2018/08/keeping-cancer-out-breath-blocks-drug-resistance

    R&DMAG
    27 Aug 2018
    Share Share